Breast cancer genetics. Implications of clinical practice.
Olufunmilayo
I
I
Department of Medicine, Pritzker School of Medicine, University of Chicago, Illinois.
Olopade
M D
MD
Fackenthal
J D
JD
D017668:Age of Onset; D016588:Anticarcinogenic Agents / Q000627:therapeutic use; D019313:BRCA1 Protein / Q000502:physiology; D024682:BRCA2 Protein; D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000517:prevention & control / Q000523:psychology; D018567:Breast Neoplasms, Male / Q000453:epidemiology / Q000235:genetics; D002277:Carcinoma / Q000453:epidemiology / Q000235:genetics* / Q000517:prevention & control / Q000523:psychology; D019090:Case Management; D019938:Cyclin D1 / Q000235:genetics / Q000502:physiology; D004252:DNA Mutational Analysis; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D005787:Gene Frequency; D019398:Genes, BRCA1; D018734:Genes, erbB-2; D005817:Genetic Counseling / Q000523:psychology; D005820:Genetic Testing / Q000523:psychology; D006801:Humans; D008297:Male; D008327:Mammography; D008408:Mastectomy; D009363:Neoplasm Proteins / Q000235:genetics / Q000502:physiology; D009378:Neoplasms, Multiple Primary / Q000235:genetics; D009386:Neoplastic Syndromes, Hereditary / Q000453:epidemiology / Q000235:genetics*; D009857:Oncogenes; D010051:Ovarian Neoplasms / Q000235:genetics; D010052:Ovariectomy; D010641:Phenotype; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D012189:Retrospective Studies; D012306:Risk; D013629:Tamoxifen / Q000627:therapeutic use; D014157:Transcription Factors / Q000235:genetics / Q000502:physiology
D016588:Anticarcinogenic Agents; D019313:BRCA1 Protein; D024682:BRCA2 Protein; D004965:Estrogen Antagonists; D009363:Neoplasm Proteins; D014157:Transcription Factors; D013629:Tamoxifen; D019938:Cyclin D1; D020849:Raloxifene Hydrochloride